Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake

被引：0
|
作者：
Hurwitz, E.
Stancovski, I.
Sela, M.
Yarden, Y.
机构：
来源：
Proceedings of the National Academy of Sciences of the United States of America | / 92卷 / 08期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] EXPRESSION OF THE ERBB-2 FAMILY OF GROWTH-FACTOR RECEPTORS AND THEIR LIGANDS IN BREAST CANCERS - IMPLICATION FOR TUMOR BIOLOGY AND CLINICAL BEHAVIOR
    BACUS, SS
    ZELNICK, CR
    PLOWMAN, G
    YARDEN, Y
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (04) : S13 - S24
  • [32] Blockade of retrograde transport in triple negative breast cancer excludes ErbB-2 isoforms from the nucleus and abrogates tumor growth
    Madera, Santiago
    Izzo, Franco
    Chervo, Maria F.
    Dupont, Agustina
    Chiauzzi, Violeta A.
    Bruni, Sofia
    Petrillo, Ezequiel
    Montero, Diego
    Merin, Sharon
    Mercogliano, Maria F.
    Proietti, Cecilia J.
    Schillaci, Roxana
    Cordo Russo, Rosalia I.
    Elizalde, Patricia V.
    CANCER RESEARCH, 2022, 82 (12)
  • [33] Effective suppression of breast tumor growth by an anti-EGFR/ErbB2 bispecific antibody
    Wang, Shuhui
    Chen, Changchun
    Meng, Yanchun
    Hu, Shi
    Zheng, Lei
    Song, Jinjing
    Zhang, Dapeng
    Li, Bohua
    Guo, Yajun
    CANCER LETTERS, 2012, 325 (02) : 214 - 219
  • [34] Monoclonal Antibodies to Fibroblast Growth Factor Receptor 2 Effectively Inhibit Growth of Gastric Tumor Xenografts
    Zhao, Wei-meng
    Wang, Lihong
    Park, Hangil
    Chhim, Sophea
    Tanphanich, Melanie
    Yashiro, Masakazu
    Kim, K. Jin
    CLINICAL CANCER RESEARCH, 2010, 16 (23) : 5750 - 5758
  • [35] Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies:: Implications for vaccine design
    Yip, YL
    Smith, G
    Koch, J
    Dübel, S
    Ward, RL
    JOURNAL OF IMMUNOLOGY, 2001, 166 (08): : 5271 - 5278
  • [36] SELECTIVE-INHIBITION OF TUMOR-CELL GROWTH BY A RECOMBINANT SINGLE-CHAIN ANTIBODY-TOXIN SPECIFIC FOR THE ERBB-2 RECEPTOR
    WELS, W
    HARWERTH, IM
    MUELLER, M
    GRONER, B
    HYNES, NE
    CANCER RESEARCH, 1992, 52 (22) : 6310 - 6317
  • [37] ANTI-HUMAN-LEUKEMIA MONOCLONAL-ANTIBODIES AND IMMUNOTOXINS FOR COMPLETE GROWTH SUPPRESSION OF TUMOR-CELLS INVITRO AND INVIVO
    SEON, BK
    LUO, Y
    YOKOTA, S
    HARUTA, Y
    MATSUZAKI, H
    EMRICH, LJ
    BARCOS, M
    CHERVINSKY, D
    TEBBI, CK
    NEW HORIZONS OF TUMOR IMMUNOTHERAPY, 1989, 852 : 329 - 348
  • [38] TUMOR-SPECIFIC ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR VARIANT-III MONOCLONAL-ANTIBODIES - USE OF THE TYRAMINE-CELLOBIOSE RADIOIODINATION METHOD ENHANCES CELLULAR RETENTION AND UPTAKE IN TUMOR XENOGRAFTS
    REIST, CJ
    ARCHER, GE
    KURPAD, SN
    WIKSTRAND, CJ
    VAIDYANATHAN, G
    WILLINGHAM, MC
    MOSCATELLO, DK
    WONG, AJ
    BIGNER, DD
    ZALUTSKY, MR
    CANCER RESEARCH, 1995, 55 (19) : 4375 - 4382
  • [39] RECOMBINANT SINGLE-CHAIN IMMUNOTOXINS SPECIFIC FOR EGF AND ERBB-2 RECEPTORS INHIBIT IN-VIVO AND IN-VITRO TUMOR-CELL GROWTH
    HYNES, NE
    MARTE, BM
    HELLMANN, P
    BEERLI, R
    GRONER, B
    WELS, W
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 237 - 237
  • [40] Novel antibodies to erbB2 which inhibit the growth of tumor cell lines expressing varying levels of receptor
    Cartlidge, Susan
    Dong, Jianying
    Babcook, John
    Kang, Jaspal
    Foltz, Ian
    Veldman-Jones, Margaret
    Vincent, John
    Blakey, David
    CANCER RESEARCH, 2009, 69
12345